TY - JOUR
T1 - Unraveling mutagenic processes influencing the tumor mutational patterns of individuals with constitutional mismatch repair deficiency
AU - Weijers, Dilys D.
AU - Hinić, Snežana
AU - Kroeze, Emma
AU - Gorris, Mark A.J.
AU - Schreibelt, Gerty
AU - Middelkamp, Sjors
AU - Mensenkamp, Arjen R.
AU - Bladergroen, Reno
AU - Verrijp, Kiek
AU - Hoogerbrugge, Nicoline
AU - Wesseling, Pieter
AU - van der Post, Rachel S.
AU - Loeffen, Jan L.C.
AU - Gidding, Corrie E.M.
AU - van Kouwen, Mariëtte C.A.
AU - de Vries, I. Jolanda M.
AU - van Boxtel, Ruben
AU - de Voer, Richarda M.
AU - Jongmans, Marjolijn C.J.
AU - Kuiper, Roland P.
N1 - © 2025. The Author(s).
PY - 2025/5/14
Y1 - 2025/5/14
N2 - Constitutional mismatch repair deficiency (CMMRD), caused by bi-allelic germline variants in mismatch repair (MMR) genes, is associated with high cancer incidence early in life. A better understanding of mutational processes driving sequential CMMRD tumors can advance optimal treatment. Here, we describe a genomic characterization on a representative collection of CMMRD-associated tumors consisting of 41 tumors from 17 individuals. Mutational patterns in these tumors appear to be influenced by multiple factors, including the affected MMR gene and tumor type. Somatic polymerase proofreading mutations, commonly present in brain tumors, are also found in a T-cell lymphoblastic lymphoma displaying associated mutational patterns. We show prominent mutational patterns in two second primary hematological malignancies after temozolomide treatment. Furthermore, an indel signature, characterized by one-base pair cytosine insertions in cytosine homopolymers, is found in 54% of tumors. In conclusion, analysis of sequential CMMRD tumors reveals diverse mutational patterns influenced by the affected MMR gene, tumor type and treatment history.
AB - Constitutional mismatch repair deficiency (CMMRD), caused by bi-allelic germline variants in mismatch repair (MMR) genes, is associated with high cancer incidence early in life. A better understanding of mutational processes driving sequential CMMRD tumors can advance optimal treatment. Here, we describe a genomic characterization on a representative collection of CMMRD-associated tumors consisting of 41 tumors from 17 individuals. Mutational patterns in these tumors appear to be influenced by multiple factors, including the affected MMR gene and tumor type. Somatic polymerase proofreading mutations, commonly present in brain tumors, are also found in a T-cell lymphoblastic lymphoma displaying associated mutational patterns. We show prominent mutational patterns in two second primary hematological malignancies after temozolomide treatment. Furthermore, an indel signature, characterized by one-base pair cytosine insertions in cytosine homopolymers, is found in 54% of tumors. In conclusion, analysis of sequential CMMRD tumors reveals diverse mutational patterns influenced by the affected MMR gene, tumor type and treatment history.
KW - Neoplastic Syndromes, Hereditary/genetics
KW - Humans
KW - Middle Aged
KW - Colorectal Neoplasms/genetics
KW - Child, Preschool
KW - Male
KW - Temozolomide/therapeutic use
KW - Brain Neoplasms/genetics
KW - Young Adult
KW - Adolescent
KW - Female
KW - Adult
KW - DNA Mismatch Repair/genetics
KW - Mutation
KW - Child
UR - https://www.scopus.com/pages/publications/105005104130
UR - https://www.mendeley.com/catalogue/3a8f136e-1d48-3afa-8767-c2b18ef934bd/
U2 - 10.1038/s41467-025-59775-2
DO - 10.1038/s41467-025-59775-2
M3 - Article
C2 - 40368937
AN - SCOPUS:105005104130
SN - 2041-1723
VL - 16
JO - Nature communications
JF - Nature communications
IS - 1
M1 - 4459
ER -